MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.actatropica.2019.01.008

Медицинская библиотека · Acta tropica · 2019

Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy.

Oyama Jully, Lera-Nonose Daniele Stéfanie Sara Lopes, Ramos-Milaré Áquila Carolina Fernandes Herculano, Padilha Ferreira Fabiana Borges, de Freitas Camila Fabiano, Caetano Wilker, Hioka Noboru, Silveira Thaís Gomes Verzignassi, Lonardoni Maria Valdrinez Campana

СтатьяПеревод пока не подготовлен

Аннотация

Leishmaniasis is a neglected disease and drugs approved for its treatment often lead to abandonment, failure of therapy and even death. Photodynamic therapy (PDT) has been shown to be a promising, non-invasive and selective for a target region without requiring high-cost technology. Usually, it is employed a photosensitizing agent (PS) incorporated into nanoparticles (NP). Pluronics® P-123 and F-127 micelles are very interesting aqueous NP promoting efficient and selective delivery and less adverse effects. This study aimed to detect the activity of Pluronics® P-123 and F-127 themselves since there is a scarcity of data on these NP activities without drugs incorporation. This study evaluated, in vitro, the activity of Pluronics® against promastigotes and amastigotes of Leishmania amazonensis and also their cytotoxicities. Additionally, the determination of the mitochondria membrane potential in promastigotes, internalization of these Pluronics® in the parasite membrane and macrophages and its stability in the culture medium was evaluated. Results showed that Pluronics® did not cause significant damage to human red cells and promastigotes. The P-123 and F-127 inhibited the survival rate of L. amazonensis amastigotes, and also presented loss of mitochondrial membrane potential on promastigotes. The Pluronics® showed low cytotoxic activity on J774A.1 macrophages, while only P-123 showed moderate cytotoxicity for BALB/c macrophages. The stability of P-123 and F-127 in culture medium was maintained for ten days. In conclusion, the NP studied can be used for incorporating potent leishmanicidal chemotherapy, due to their selectivity towards macrophages, being a promising system for the treatment of cutaneous leishmaniasis.

Для цитирования: Oyama Jully, Lera-Nonose Daniele Stéfanie Sara Lopes, Ramos-Milaré Áquila Carolina Fernandes Herculano, Padilha Ferreira Fabiana Borges, de Freitas Camila Fabiano, Caetano Wilker, Hioka Noboru, Silveira Thaís Gomes Verzignassi, Lonardoni Maria Valdrinez Campana. Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy.. Acta tropica. 2019. DOI: 10.1016/j.actatropica.2019.01.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.